Tali Notman - Aug 1, 2024 Form 4 Insider Report for JFrog Ltd (FROG)

Role
CHIEF REVENUE OFFICER
Signature
/s/ Shanti Ariker, Pursuant to a Power of Attorney
Stock symbol
FROG
Transactions as of
Aug 1, 2024
Transactions value $
-$508,759
Form type
4
Date filed
8/5/2024, 06:25 PM
Previous filing
Jul 3, 2024
Next filing
Sep 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FROG Ordinary Shares Options Exercise $189K +12.5K +2.24% $15.12 572K Aug 1, 2024 Direct
transaction FROG Ordinary Shares Options Exercise $403K +17.5K +3.06% $23.00 589K Aug 1, 2024 Direct
transaction FROG Ordinary Shares Sale -$471K -13.2K -2.24% $35.70 576K Aug 1, 2024 Direct F1, F2
transaction FROG Ordinary Shares Sale -$227K -6.18K -1.07% $36.72 570K Aug 1, 2024 Direct F1, F3
transaction FROG Ordinary Shares Sale -$366K -9.69K -1.7% $37.80 560K Aug 1, 2024 Direct F1, F4
transaction FROG Ordinary Shares Sale -$35.8K -929 -0.17% $38.50 559K Aug 1, 2024 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FROG Employee Share Option (right to buy) Options Exercise $0 -12.5K -14.66% $0.00 72.8K Aug 1, 2024 Ordinary Shares 12.5K $15.12 Direct F6
transaction FROG Employee Share Option (right to buy) Options Exercise $0 -17.5K -24.04% $0.00 55.3K Aug 1, 2024 Ordinary Shares 17.5K $23.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2024.
F2 This transaction was executed in multiple trades at prices ranging from $35.31 to $36.3. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $36.32 to $37.32. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $37.34 to $38.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $38.41 to $38.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 10,000 ordinary shares subject to the option vested on January 13, 2021, and the remaining shares subject to the option vest in 13 quarterly installments thereafter.
F7 25% ordinary shares subject to the option vested on July 29, 2021, and the remaining shares subject to the option vest in 16 equal quarterly installments thereafter.